The 17th ESDPPP congress was held in Basel Switzerland, from 28-30 May 2019.

The following topics were covered at the meeting:

• How to better use model-based adaptive trial design in paediatrics
• Development of an international guideline on paediatric extrapolation (ICH)
• Child friendly, age-appropriate formulations: how important are excipients?
• Drug formularies for children: time for a global approach!
• Adverse drug reactions across the paediatric age continuum
• Personalized medicine in children: more than just development?
• Pharmacogenomics: a cornerstone of precision medicine for childhood cancer
• New emerging therapies for genetic diseases (e.g., mucopolysaccharidoses, Duchenne muscular dystrophy, spinal muscular dystrophies, cystic fibrosis)
• Immunotherapy for paediatric cancer
• Pharmacology of cannabis in adolescents
• Personalized optimal dosing computation in neonates and children with thyroid diseases
• How to dose neonates and children during ECMO, haemodialysis and haemofiltration
• Alternative avenues to perform Therapeutic Drug Monitoring: use of saliva, dry blood spots and exhaled air!
• Implementation of e-health devices in clinical and pharmacological research in kids
• The role of the placenta in fetal and perinatal pharmacology
• Drug-drug interactions and education of health care providers
• How to conduct a successful neonatal clinical trial: the example of inhaled steroids
• How to optimize the use of microdosing in the neonatal and paediatric pharmacology
• Optimal use of antibacterial agents in the neonatal and paediatric population across the globe
• The opioid epidemic: what is new in the area of neonatal abstinence syndrome
• How to optimize pharmacotherapy in paediatric obesity
• New approaches in the treatment of pulmonary hypertension
• Update on research infrastructures across the globe (i-ACT, IMI2, FDA-funded clinical trial research networks)

Available material